Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Лечение невропатической боли с позиций доказательной медицины
Лечение невропатической боли с позиций доказательной медицины
Чурюканов М.В., Катушкина Э.А. Лечение невропатической боли с позиций доказательной медицины. Consilium Medicum. 2014; 16 (2): 71–74.
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Treede RD, Jensen TS, Campbell JN et al. Neuropathic pain: redefinition and a grading system for clinical research purposes. Neurology 2008; 70: 1630–5.
2. Gore M, Brandenburg NA, Hoffman DL et al. Burden of illness in painful diabetic peripheral neuropathy: the patients’ perspectives. Pain 2006; 7: 892–900.
3. Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology 2007; 68: 1178–82.
4. McDermott AM, Toelle TR, Rowbotham DJ et al. The burden of neuropathic pain: results of a cross-sectional survey. Eur J Pain 2006; 10: 127–35.
5. O’Connor AB. Neuropathic pain: a review of the quality of life impact, costs, and cost-effectiveness of therapy. Pharmacoeconomics 2009; 27: 95–112.
6. Oster G, Harding G, Dukes E et al. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. Pain 2005; 6: 356–63.
7. Алексеев В.В., Яхно Н.Н. Боль. Болезни нервной системы. Руководство для врачей. Под ред. Н.Н.Яхно и Д.Р.Штульмана. М.: Медицина, 2001. Т. 1; с. 106–24.
8. Решетняк В.К., Кукушкин М.Л. Боль: физиологические и патофизиологические аспекты. Актуальные вопросы патофизиологии (избранные лекции). Под ред. Б.Б.Мороза. М.: Медицина, 2001; с. 354–89.
9. Coderre TJ, Katz J, Vaccarino AL et al. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993; 52: 259–85.
10. Bonica JJ. Introduction: semantic, epidemiologic, and educational issues. Pain and central nervous system disease: The central pain syndromes. Casey K.L., editor. New York: Raven Press, 1991; p. 13–29.
11. Smith BH, Torrance N, Bennett MI, Lee AJ. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clin J Pain 2007; 23: 143–9.
12. Torrance N, Smith BH, Watson MC, Bennett MI. Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin. Fam Pract 2007; 24: 481–5.
13. Dworkin RH, O’Connor AB, Backonja M et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007; 132: 237–51.
14. Moulin DE, Clark AJ, Gilron I et al., for the Canadian Pain Society. Pharmacological management of chronic neuropathic pain – consensus statement and guidelines from the Canadian Pain Society. Pain Res Manage 2007; 12: 13–21.
15. Attal N, Cruccu G, Haanpää M et al, for the EFNS Task Force. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13: 1153–69.
16. Oxford Centre for Evidence-based Medicine. Levels of evidence and grades of recommendation. http://www.cebm.net/index.aspx?o=1025
17. Cruccu G, Aziz TZ, Garcia-Larrea L et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 2007; 14: 952–70.
18. Колосова О.А., Осипова В.В. Современные аспекты клиники и патогенеза мигрени. Журн. невропатологии и психиатрии им. С.С.Корсакова. 1991; 5: 104–6.
19. Keefe FJ, Lefebvre J. Pain behavior concepts: Controversies, current status and future directions. In: G.Gebhart, D.L.Hammond, T.S.Jensen. Proceedings of the VII World Congress of Pain. New York: Elsevier, 1994; p. 127–48.
20. Sanders SH. Behavior assessment of clinical pain: appraisal of current status. New York: Academic Press. 1979; 8.
21. Wade JB, Price DD, Hamer R et al. An emotional component analysis of chronic pain. Pain 1990; 40: 303–10.
22. Haythornthwaite JA, Sieber WJ, Kerns RD. Depression and the chronic pain experience. Pain 1991; 46: 177–84.
23. Lynn R, Eysenck HJ. Tolerance for pain, extraversion and neuroticism. Percept Mot Skills 1961; 12: 161–2.
24. Рябус М.В. Лечение головной боли напряжения методом биологической обратной связи. Дис. канд. мед. наук. М., 1998.
2. Gore M, Brandenburg NA, Hoffman DL et al. Burden of illness in painful diabetic peripheral neuropathy: the patients’ perspectives. Pain 2006; 7: 892–900.
3. Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology 2007; 68: 1178–82.
4. McDermott AM, Toelle TR, Rowbotham DJ et al. The burden of neuropathic pain: results of a cross-sectional survey. Eur J Pain 2006; 10: 127–35.
5. O’Connor AB. Neuropathic pain: a review of the quality of life impact, costs, and cost-effectiveness of therapy. Pharmacoeconomics 2009; 27: 95–112.
6. Oster G, Harding G, Dukes E et al. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. Pain 2005; 6: 356–63.
7. Алексеев В.В., Яхно Н.Н. Боль. Болезни нервной системы. Руководство для врачей. Под ред. Н.Н.Яхно и Д.Р.Штульмана. М.: Медицина, 2001. Т. 1; с. 106–24.
8. Решетняк В.К., Кукушкин М.Л. Боль: физиологические и патофизиологические аспекты. Актуальные вопросы патофизиологии (избранные лекции). Под ред. Б.Б.Мороза. М.: Медицина, 2001; с. 354–89.
9. Coderre TJ, Katz J, Vaccarino AL et al. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993; 52: 259–85.
10. Bonica JJ. Introduction: semantic, epidemiologic, and educational issues. Pain and central nervous system disease: The central pain syndromes. Casey K.L., editor. New York: Raven Press, 1991; p. 13–29.
11. Smith BH, Torrance N, Bennett MI, Lee AJ. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clin J Pain 2007; 23: 143–9.
12. Torrance N, Smith BH, Watson MC, Bennett MI. Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin. Fam Pract 2007; 24: 481–5.
13. Dworkin RH, O’Connor AB, Backonja M et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007; 132: 237–51.
14. Moulin DE, Clark AJ, Gilron I et al., for the Canadian Pain Society. Pharmacological management of chronic neuropathic pain – consensus statement and guidelines from the Canadian Pain Society. Pain Res Manage 2007; 12: 13–21.
15. Attal N, Cruccu G, Haanpää M et al, for the EFNS Task Force. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13: 1153–69.
16. Oxford Centre for Evidence-based Medicine. Levels of evidence and grades of recommendation. http://www.cebm.net/index.aspx?o=1025
17. Cruccu G, Aziz TZ, Garcia-Larrea L et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 2007; 14: 952–70.
18. Колосова О.А., Осипова В.В. Современные аспекты клиники и патогенеза мигрени. Журн. невропатологии и психиатрии им. С.С.Корсакова. 1991; 5: 104–6.
19. Keefe FJ, Lefebvre J. Pain behavior concepts: Controversies, current status and future directions. In: G.Gebhart, D.L.Hammond, T.S.Jensen. Proceedings of the VII World Congress of Pain. New York: Elsevier, 1994; p. 127–48.
20. Sanders SH. Behavior assessment of clinical pain: appraisal of current status. New York: Academic Press. 1979; 8.
21. Wade JB, Price DD, Hamer R et al. An emotional component analysis of chronic pain. Pain 1990; 40: 303–10.
22. Haythornthwaite JA, Sieber WJ, Kerns RD. Depression and the chronic pain experience. Pain 1991; 46: 177–84.
23. Lynn R, Eysenck HJ. Tolerance for pain, extraversion and neuroticism. Percept Mot Skills 1961; 12: 161–2.
24. Рябус М.В. Лечение головной боли напряжения методом биологической обратной связи. Дис. канд. мед. наук. М., 1998.
Авторы
М.В.Чурюканов1, Э.А.Катушкина2
1. ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава России;
2. ФГБУ НИИ общей патологии и патофизиологии РАМН, Москва
1. ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава России;
2. ФГБУ НИИ общей патологии и патофизиологии РАМН, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.